Blog

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Blog

David Braun: We can make a personalized vaccine to target those tumor-specific antigens

Photo taken from www.yalemedicine.org/specialists/david-braun

Sep 2, 2024, 08:40

David Braun: We can make a personalized vaccine to target those tumor-specific antigens

Dana-Farber Cancer Institute shared a post on X:

“’If we can identify neoantigens specific to a patient’s tumor, we can make a personalized vaccine to target those tumor-specific antigens,’ says David Braun, MD, PhD, a Dana-Farber oncologist leading a trial of a neoantigen-based vaccine for kidney cancer.”

David Braun: We can make a personalized vaccine to target those tumor-specific antigens

Read further.
Source: Dana-Farber Cancer Institute/X

cancer cancer immunotherapy Cancer research cancer treatment Dana-Farber Cancer Institute David Braun MD PhD immuno-oncology kidney cancer neoantigen OncoDaily Oncology oncology trials personalized vaccine tumor-specific antigens vaccine development

Sep 2, 2024, 08:40

Durable Responses to Atezolizumab Plus Bevacizumab in HCC

Sep 2, 2024, 08:40

David Braun: We can make a personalized vaccine to target those tumor-specific antigens

Sep 2, 2024, 08:38

Aaron Goodman: Very rare case of subcutaneous panniculitis T-cell lymphoma

Sep 2, 2024, 08:35

Shilpa Gupta: Novel approach of intermittent IO in mRCC

Sep 2, 2024, 08:32

Drew Moghanaki: Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC

Sep 2, 2024, 08:32

Digital twin will help oncologists make evidence-based decisions in the future - Oncology Advance

Sep 2, 2024, 08:21

Carrie Pfluke honor her mom's memory & help other families - Wilmot Cancer Institute

Sep 2, 2024, 07:47

Zainab Shinkafi-Bagudu: Celebrating the heritage, culture, and contributions of African people worldwide

Sep 2, 2024, 07:29

AARM 2024 Conference to Feature Dedicated Session on Autism and Cancer

Sep 2, 2024, 07:25

Mohammad Jad Moussa: Thrilled to share my selection as a top recipient of the Trainee Abstract Competition for TxSCO2024

Sep 2, 2024, 07:22

Chris Hourigan: Build your cancer research program at the new Virginia Tech Fralin Biomedical Research Institute Cancer Research Center

Sep 2, 2024, 07:17

The 2024 DF/HCC Breast Cancer Program Research Retreat - Dana-Farber’s Breast Oncology Center